Guiyang Medical University

education 📍 Guiyang, China
2
Lidocaine Infusion Publications
5
Lidocaine Infusion Researchers

Associated Institutions

Affiliated Hospital of Guizhou Medical University
related

Publications

The effect of continuous intravenous lidocaine infusion on postoperative analgesia in elderly patients undergoing laparoscopic colorectal surgery.

Wan Q, Yi Q, Huang R, Wang N, Zeng Q
BMC anesthesiology

This study aimed to evaluate the effect of continuous intravenous infusion of different doses of lidocaine on postoperative analgesia in elderly patients undergoing laparoscopic colorectal surgery. In this prospective, randomized, double-blind pilot study, elderly patients undergoing laparoscopic colorectal surgery at the Affiliated Cancer Hospital of Guizhou Medical University between January 2024 and February 2025 were enrolled. All patients received anterior quadratus lumborum block under ultrasound guidance combined with general anesthesia. Participants were randomized into three groups based on the lidocaine infusion dose after tracheal intubation: Group L (1.0 mg/kg/h), Group M (1.5 mg/kg/h), and Group H (2.0 mg/kg/h). The primary outcome was postoperative pain intensity assessed by the Numeric Rating Scale (NRS) at predefined time points. Secondary outcomes included patient-controlled analgesia (PCA) usage, postoperative opioid consumption, requirement of intraoperative ephedrine, Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) scores, and incidence of postoperative adverse events. A total of 114 patients aged ≥ 65 years (52 males and 62 females) were included with 38 cases in each group. Baseline demographic and clinical characteristics were comparable among the three groups. There were significant differences in postoperative pain NRS scores at 12-hour and 24-hour among three groups (both  < 0.001). Compared with the L group, the postoperative 12-hour and 24-hour pain NRS scores were significantly lower in both the M and H groups ( < 0.05) Compared to Group L, both Group M and Group H demonstrated significantly reduced cumulative PCA usage and postoperative opioid consumption ( < 0.05). Group H showed a higher requirement for intraoperative ephedrine compared to Groups L and M ( < 0.05). Upon entry into the post-anesthesia care unit, Groups L and M had significantly higher MOAA/S scores than Group H ( < 0.05). No significant differences were found in the incidence of adverse events among three groups ( > 0.05). In elderly patients undergoing laparoscopic colorectal surgery, continuous intravenous lidocaine infusion at 2.0 mg/kg/h significantly reduced postoperative pain intensity at 12 and 24 h compared with 1.0 mg/kg/h. Based on these findings, the effective dosage range appears to be 1.5–2.0 mg/kg/h. Further studies with larger sample sizes are needed to confirm these results. ChiCTR2500097315 (Retrospectively registered).

Lidocaine-Based vs Sufentanil-Based PCIA After Pulmonary Resection Surgery: A Randomized Controlled Trial.

Tian B, Wu Y, Zhang W, Liu R, Qu S , et al.
Drug design, development and therapy

We investigated the efficacy and safety of lidocaine-based patient-controlled intravenous analgesia (PCIA), compared with sufentanil-based PCIA on postoperative pain and recovery quality in patients undergoing thoracoscopic lung surgery. We recruited 160 patients undergoing thoracoscopic lung surgery who were randomized to receive lidocaine-based PCIA (1.5 mg/kg/h) or sufentanil-based PCIA (2 μg/mL) within 48 hours postoperatively. The primary endpoint was visual analogue scores (VAS) pain scores at 6, 12, 24, and 48 hours postoperatively. Postoperative quality of recovery-15 (QoR-15) scores and other prespecified endpoints were also recorded. VAS pain scores at rest and during coughing in the lidocaine group were significantly lower at 6, 12, and 24 hours postoperatively (<0.05), with no difference at 48 hours (0.05). QoR-15 scores in the lidocaine group were higher on postoperative day (POD) 1 (<0.001) and POD2 (<0.001), with significant differences in the two dimensions of postoperative physical comfort and pain (<0.001). The lidocaine group also experienced a shorter time to first flatus, defecation, and ambulation (<0.05), with no difference in the length of postoperative hospitalization and thoracic drainage time (0.05). The serum IL-6, TNF-α, IL-8, cortisol, and epinephrine concentrations were lower in the lidocaine group on POD1 and POD2 (<0.05). The incidence of postoperative nausea and vomiting in the lidocaine group was lower (<0.05), with no differences in other adverse events (>0.05). Compared with sufentanil-based PCIA, lidocaine-based PCIA significantly relieved postoperative pain and improved recovery quality after thoracoscopic lung surgery with fewer postoperative adverse events, which is a considerable choice for postoperative analgesia. This study was retrospectively registered at the Chinese Clinical Trial Registry on March 1st, 2023 (number ChiCTR2300068840).